
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [EDIT] Editas Medicine Inc
Data updated 2025-Apr-17 (Thursday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab

Share
2025-Apr-17 Thursday
Open | $1.28 | High | $1.31 +2.34% |
---|---|---|---|
Close | $1.28 | Low | $1.25 -2.34% |
Volume | 743 Thousand 0.75x | Volatility | 4.80% |
Change |
+$0.01
+0.79%
|
Streak | ↑ 1 days +0.79% |
20d SMA | $1.21 +5.8% | 50d SMA | $1.47 -12.6% | 100d SMA | $1.52 -15.5% | 200d SMA | $2.70 -52.6% |
RSI | 49 | MACD | 0.04 | ADX | 16.9 | Stochastic Oscillator | 72.2 80.3 |
CCI | 49.7 | ATR | 0.14 | OBV | -47.1 Million | Chaikin A/D | -156 Million |
Market Cap | 106 M | PEG Ratio | 0 | Trailing P/E | Forward P/E | 0 | |
Price/Sales (ttm) | 3.29 | Price/Book (mrq) | 0.792 | EV/Revenue (ttm) | 1.25 | EV/EBITDA (ttm) | -1.36 |
% Held by Insiders | 0.91% | % Held by Institutions | 75.61% | Shares Short | 13.9 M | Shares Short (prior month) | 12.6 M |
Short Ratio | 5.91 | Short % of Outstanding | 16.64% | Short % of Float | 18.85% | Shares Short Change (mom) | +10.6% |
Revenue/Share (ttm) | $0.39 | Profit Margin (ttm) | 0.00% | Operating Margin (ttm) | -112.30% | EBITDA (ttm) | -233 M |
Diluted EPS (ttm) | $-2.88 | Current Ratio (mrq) | 5.39 | Return on Assets (ttm) | -35.50% | Return on Equity (ttm) | -98.10% |
Qtr Earnings Growth (yoy) | 0.00% | Qtr Revenue Growth (yoy) | -49.00% | Operating Cash Flow (ttm) | -132 M | Free Cash Flow (ttm) | -87.8 M |
Choose view type
Daily Performance for Editas Medicine Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Editas Medicine Inc up to close of 2025-Apr-17 at $1.28
2-month Performance Benchmarks for Editas Medicine Inc:
Related to Editas Medicine Inc
Information for Editas Medicine Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-17 on Google
SEC Reports : Quarterly reports around 2025-Apr-17 on SEC Edgar
Compare Editas Medicine Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Editas Medicine Inc
Industry : Biotechnology industry performance which includes Editas Medicine Inc